Home / Import refusals / SCS-9488969-2/341/1

FDA Import Refusal SCS-9488969-2/341/1 — Cipla Limited

Cipla Limited — FEI 3007021905

The FDA refused shipment SCS-9488969-2/341/1 from Cipla Limited (India) on April 14, 2025. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
April 14, 2025
Country
India
Product Category
Drugs and Biologics
Product Code
61JCC08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
Charges
75

Recent inspections

  • 968467 (NAI Fri Mar 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 886613 (OAI Wed Jun 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 750585 (VAI Thu Sep 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 1FX-3441591-9/20002/4 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-1905741-3/20002/4 (Fri Jun 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-1905741-3/20002/5 (Fri Jun 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-4688178-4/10002/1 (Tue Jun 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-9797841-4/20002/1 (Tue Jun 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources